This program is not designed to diagnose, treat, cure, or prevent any medical condition
Gradual dose escalation and monitored weight loss form the cornerstone of risk reduction
The exclusion criteria were: females who were pregnant or experiencing a menstrual period, type 2 diabetes treated using an insulin regimen, malignancy, hematopathy, active tuberculosis, peptic ulcer with gastric bleeding, binge-eating disorder, psychiatric disease, congestive heart failure, clinically relevant renal or hepatic insufficiency, unstable coronary artery disease, cancer or a history of cancer
Athletes subject to drug testing should avoid IGF-1 LR3 entirely